Lymphangioma — Trials

Lymphangioma — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00975819	Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies	completed	Phase 2	61	Denise Martin AdamsOTHER	1	Jan 6, 2026	clinicaltrials
NCT06943703	Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma	completed	—	809	National Children's Hospital, VietnamOTHER	1	Apr 24, 2025	clinicaltrials
NCT05050149	Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations	completed	Phase 2	12	Palvella Therapeutics, Inc.INDUSTRY	1	Jan 17, 2025	clinicaltrials
NCT06257719	Clinical Characteristics of Lymphatic Malformations

Data updated 22 days agoSource updated Jan 6, 2026source: clinicaltrials